VisEn Medical raises $7 million; adds Merck CEO to board
VisEn Medical, an in vivo imaging developer, has completed its Series B financing.
The Woburn, Mass.-based VisEn received $7 million from an investment round, co-led by Merck Capital Ventures of Woodcliff Lake, N.J., and Flagship Ventures of Cambridge, Mass., which also included the Boston-based Bollard Group and other existing investors.
Also, Per Lofberg, the president and CEO of Merck Capital Ventures, will join VisEn Medical’s board of directors. Lofberg was formerly chairman of the board at Medco Health, according to VisEn.
The Woburn, Mass.-based VisEn received $7 million from an investment round, co-led by Merck Capital Ventures of Woodcliff Lake, N.J., and Flagship Ventures of Cambridge, Mass., which also included the Boston-based Bollard Group and other existing investors.
Also, Per Lofberg, the president and CEO of Merck Capital Ventures, will join VisEn Medical’s board of directors. Lofberg was formerly chairman of the board at Medco Health, according to VisEn.